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Abstract
Background: Francisella tularensis is a prototypic example of a pathogen for which few experimental datasets exist,
but for which copious high-throughout data are becoming available because of its re-emerging significance as
biothreat agent. The virulence of Francisella tularensis depends on its growth capabilities within a defined
environmental niche of the host cell.
Results: We reconstructed the metabolism of Francisella as a stoichiometric matrix. This systems biology approach
demonstrated that changes in carbohydrate utilization and amino acid metabolism play a pivotal role in growth,
acid resistance, and energy homeostasis during infection with Francisella. We also show how varying the
expression of certain metabolic genes in different environments efficiently controls the metabolic capacity of
F. tularensis. Selective gene-expression analysis showed modulation of sugar catabolism by switching from oxidative
metabolism (TCA cycle) in the initial stages of infection to fatty acid oxidation and gluconeogenesis later on.
Computational analysis with constraints derived from experimental data revealed a limited set of metabolic genes
that are operational during infection.
Conclusions: This integrated systems approach provides an important tool to understand the pathogenesis of an
ill-characterized biothreat agent and to identify potential novel drug targets when rapid target identification is
required should such microbes be intentionally released or become epidemic.
Background
Emerging or re-emerging infectious agents are rarely
subject of extensive preceding experimental investiga-
tions by sheer implication of their definition, as they
would, for example, exist for model pathogens such as
Salmonella. Even when their potential for global pan-
demics or for being used as biothreat agents is recog-
nized, in-depth data cannot be easily generated in a
timely fashion. While high-throughput data such as full
genome sequences, microarray gene expression profiles,
or proteomic data can be obtained quite efficiently for
the pathogen in question, the context for proper inter-
pretation of such data is often missing. One such case is
represented by Francisella tularensis, the causative agent
o ft u l a r e m i a[ 1 ] .T h i sp a t h o g e ni sh i g h l yi n f e c t i o u sa n d
can cause fatal systemic disease after inhalation of as lit-
tle as 10 organisms. This extremely low infectious dose,
ease of transmission via the aerosol route, and previous
attempts to weaponize this microbe have led to its
recognition as a biothreat agent [2]. Extensive research
over the last years in the field of tularemia after the full
potential of Francisella had been recognized has been
focused on vaccine development, virulence factors, and
whole genomic sequencing of Francisella isolates. There
are few data sets for the physiological characterization
of this bacterium during infection. Its central metabolic
pathways still remain largely uncharacterized. However,
growth of Francisella within macrophages or other
potential host cells depends on its ability to utilize avail-
able nutrients and exploit this niche by presumably
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the success of Francisella as an intracellular pathogen.
At the same time, critical bacterial metabolic pathways
represent the most likely targets for novel antibacterial
strategies. In this setting computational systems biology
approaches may facilitate the integration of high-
throughput data, exclude redundant possibilities, and
suggest novel hypotheses.
Constraints-based systems analysis after reconstruc-
tion of genome scale metabolic networks has emerged
as a suitable tool for such tasks [3]. This type of recon-
struction allows the evaluation of metabolic networks
through flux balance and variability analysis, in silico
gene deletion analysis, robustness analysis, and the suc-
cessive application of other suitable constraints. Such
analysis has already been implemented for organisms
from all the three classes (archae, bacteria and eukar-
yotes) including E. coli [4], Salmonella [5], Haemophilus
[6], Saccharomyces [7], and Leishmania [8]. For these
organisms, large traditional and high-throughput experi-
mental datasets were available. Here we employ this
approach for Francisella tularensis with the goal of pro-
viding a framework for the integration of existing high-
throughput data that might be used for interrogating
pathogenesis and for identifying novel antibacterial
targets.
Results
Reconstruction and analysis of the metabolic network of
F. tularensis
The reconstruction process for building a metabolic net-
work for Francisella tularensis subspecies holarctica
vaccine strain (F. tularensis LVS) is described in detail
in Material and Methods and followed previously
described procedures [9,3]. The network reconstruction
statistics for iRS605, which has 683 genes, 547 proteins,
and 605 intra-system reactions, are summarized in Fig-
ure 1A. Throughout this manuscript iRS605 refers to
the metabolic reconstruction of Francisella LVS. The
low number of reactions in the reconstruction as com-
pared to similar models like E. coli and Salmonella is
the result of a reduced set of metabolic pathways in this
organism and of limited legacy data to confirm the
annotation of its genome. The reconstruction includes
481 single gene protein reaction relationships (GPR) and
66 multigene GPRs (Additional File S1). The genes
included in the model represent those for which geno-
mic, transcriptomic or physiological data exist in the lit-
erature in the form of gene-protein specific
biochemistry or large-scale screens. Genes with high
sequence homology to genes in other Francisella strains
such as Schu4 or OSU118 are also included in the
model. There are 55 non-gene associated reactions
included in the model that lack experimental evidence
but are essential for validation and prediction of a phy-
siological phenotype in silico (Additional File S1C).
Gap analysis of the model identified several gaps in
the network. There are gaps in a network when certain
metabolites can only be consumed or produced. Since
Francisella has several pathways that are disrupted or
that miss genes [10], there are 102 dead end metabolites
in the Francisella network (Additional File S2). The
reactions catalyzed by these genes form a set of reac-
tions whose presence or absence provide important
hypotheses on possible connecting reactions that can be
further experimentally investigated and can thus lead to
efficient annotation of the genome. With this, a more
functionally complete network can be obtained.
The distribution of pathway functions are summarized
in Figure 1B. Twenty five percent of those constitute
amino acid metabolism [10,3]. When these biosynthetic
pathways are disrupted the respective compound is
required as an essential component of a synthetic med-
ium for growth. The partial amino acid pathways identi-
fied that are essential for growth [11,12] include those
for Asp, Cys, Ser, Thr, Met, Tyr, Lys, Pro, Arg, His, Val,
Ile, and Leu and comprise a significant part of the bac-
terial network.
Pathways identified to be incomplete by gap analysis
and confirmed using gene sequence data are discussed
below. Central metabolic pathways that are incomplete
include the pentose phosphate pathway and glycolysis.
The genome encodes all glycolytic genes but lacks the
phosphofructokinase (PfkA) gene. Constraints based
analysis suggests that the presence of fructose bispho-
sphatase (Fbp), allows Francisella to build up complex
carbohydrates by gluconeogenesis. This suggests the
use of the Embden-Meyerhof-Parnas (EMP) pathway
for gluconeogenesis rather than glycolysis. The patho-
g e ni st h e na b l et os y n t h e s i z eg l u c o s ef r o mp y r u v a t e ,
since it encodes phosphoenolpyruvate (PEP) carboxy-
lase. This allows gluconeogenesis starting from oxaloa-
cetate. Despite an incomplete glycolytic pathway and
only an oxidative branch of the pentose phosphate
pathway, genes predicted to encode sugar uptake sys-
tems might at least ensure partial energy generation
via the oxidization of hexoses. The retention of trans-
ketolase and transaldolase genes of the nonoxidative
branch of the pentose phosphate pathway indicates the
ability to regenerate glucose-6-phosphate and oxidize
hexoses to pyruvate, although without an energy yield.
For energy generation, Francisella may thus prefer to
oxidize amino acids or other organic compounds
derived from the host. Thus network reconstruction
and constraints-based analysis identify condition-
dependent operational pathways that throw light on
adjustments the organism is capable of making in
different environments.
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Figure 1
F. tularensis genome size 1,857,432 bp
Open Reading Frames 1802
iRS605 in silico F.  tularensis characteristics
Genes 683
Proteins 547
Reactions 605
Gene associated 547
Non-gene associated 58
Intracellular metabolites 586
C
Figure 1 Reconstruction characteristics for iR S 6 0 5 .A .S t a t i s t i c so ft h eFrancisella tularensis subspecies holarctica vaccine strain
(F. tularensis LVS) genome and its in silico reconstruction iRS605. The in silico representation includes gene-protein-reaction relationships
including isozymes, multimeric protein complexes, and multi-reaction catalyzing enzymes as described in the text. B. Functional classification of
genes that are included in the model. C. Overview of metabolism in Francisella. Significant interconnections between pathways are shown.
Pathways with missing genes are indicated by cross symbols.
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biosynthesis in Francisella are virtually identical to those
in E.coli. Several glycerol and phospholipid biosynthesis
pathways are present in Francisella including phosphati-
dyl serine. However, there is no evidence for cardiolipin
synthesis [14]. Orthologs of cardiolipin synthase are also
absent. Diaminopimelic acid (DAP), which is an inter-
mediate of lysine biosynthesis and an important com-
pound in cell wall biosynthesis, cannot be synthesized,
although lysine itself can be synthesized.
Although PAPS reductase is missing, Francisella is
able to reduce sulfate to sulfide for macromolecule
synthesis via the APS-PAPS pathway and eventually fix
as cysteine. This may mean broader specificities of the
enzymes involved and further emphasizes the need to
test experimentally the predicted gaps in Francisella
metabolism.
The majority of transport systems present in Franci-
sella are secondary carriers [10]. The remaining trans-
port systems are ABC-type carriers, consisting of a
membrane-spanning permease and an ATP-binding
subunit. Interestingly, periplasmic substrate-binding
proteins, which usually are an integral part of such
transport systems, are missing in most ABC-type car-
riers. Very few permeases that catalyze transport by a
concentration gradient are found. In accordance with
the advanced degeneration of its amino acid biosyn-
thetic capability as discussed earlier, Francisella has
retained several transport systems for amino acids [15],
including LysE and SdaC, that are both secondary car-
riers for branched chain and hydroxy amino acids.
There is also evidence for aquaglyceroporin GlpF that
is involved in glycerol and water transport. It may also
accept other small, uncharged organic molecules such
as urea, glycine, or glycerolaldehyde as substrates.
Francisella seems to posses uptake systems for several
minerals and salts including a low and high affinity
transport system for potassium [10,16], a secondary
carrier for inorganic phosphate, and an antiport system
for Na/H. Francisella also encodes an ABC transporter
for manganese and zinc.
Figure 1C is a concise overview of iRS605 of the Fran-
cisella metabolic network. It emphasizes evidence of
metabolic function for different pathways although
many intermediate reactions are found missing. This
does not reduce the significance of the pathway or reac-
tion in the growth and survival of Francisella,a n ds u g -
gests dependence on the host for that particular
function. Francisella seems to have kept redundant
enzyme function to a minimum (lower number of
isozymes) with metabolic analysis suggesting a broader
specificity for enzymes.
Metabolic functional states and in silico growth of
Francisella tularensis iRS605
A constraints based flux balance model was derived
from this metabolic reconstruction that can be used to
predict growth both qualitatively and quantitatively
under specified conditions. Flux balance analysis is set
up as a linear optimization problem with maximization
of the biomass function as the objective. This biomass
objective function was defined by conducting experi-
mental measurements for macromolecular composition
of F. tularensis. The biomass objective function was
defined using experimental data and literature for che-
mical composition studies of F. tularensis and includes
metabolites in addition to experimentally determined
growth associated ATP maintenance costs. We
accounted for absence of phospholipids like cardiolipin
that form integral parts of biomass in other organisms
like E.coli and Salmonella. The reconstruction of the
biomass function is critical to the success of the model
in predicting physiological behaviors (equivalent to func-
tional states of the network) since it defines the drain on
several metabolites to make macromolecules that deter-
mine the biomass composition.
iRS605 was grown in silico by specifying appropriate
exchange fluxes (Additional File S3) in defined Cham-
berlain media and using Flux Balance Analysis (FBA) to
maximize the defined biomassf u n c t i o n( d e s c r i b e di n
detail in Methods). Calculated physiological states of
F. tularensis indicate that amino acids can provide all
the bulk carbon requirements for growth. Biomass pro-
duction changed on varying amino acid concentration,
which correlates with experimental data. Thirty-six per-
cent of the total metabolic reactions were estimated to
be operational (non zero flux value) during growth of
F. tularensis on Chamberlain’s minimal media supple-
mented with glucose. This is higher than found in other
bacteria such as E. coli and Salmonella [5] that use only
25% of their metabolic capacity to accomplish the same
goal. Also, higher rates of ammonia exchange (up to
4 times) were predicted for Francisella than for Salmo-
nella. Ammonia exchange was estimated using flux bal-
ance analysis. Amino acids were not only incorporated
into biomass but also used for energy generation in
Francisella. The molar fraction of the amino acids in
biomass was experimentally determined (data not
shown) and used to specify coefficients in the biomass
equation. Different ATP requirements for growth and
maintenance were thus incorporated in the Francisella
model by combining specific growth rates, substrate
uptake data, and flux balance analysis [17]. The accuracy
of the model-predicted growth rates is dependent on
this and was confirmed by comparing physiological
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below). Growth experiments and metabolic phenotyping
for the pathogen in addition to existing literature were
used for this purpose.
Model iRS605 accurately predicts gene essentiality and
virulence
iRS605 was used to perform in silico gene deletion stu-
dies that carry the potential to identify antibiotic drug
targets. The model was initially used to determine con-
dition dependent essential metabolic genes (lethal genes)
needed for growth and survival. The conditions chosen
were Chamberlain media with no additional carbon/
energy source, Chamberlain media with six different pri-
mary carbon/energy sources (glucose, fructose, arabi-
nose, ribose, xylose and glycerol), a rich media designed
to simulate conditions found in macrophages, and com-
plex Mueller-Hinton broth. Gene essentiality was
assessed by deleting single reactions in silico and testing
for growth. The essentiality of a given gene was deter-
mined by calculating the maximal growth rate using
FBA when fluxes through associated reactions were con-
strained to be zero. This type of analysis identifies lethal
gene deletions (where maximum growth rate is zero)
and non-lethal gene deletions (where maximum growth
rate is greater than zero. Isozymes and multi-unit
enzymes and protein complexes are represented using
Boolean logic and hence deletion of an enzyme subunit
would force flux values through associated reactions to
be zero, unless other isozymes are present. In environ-
ments where uptake reactions (available nutrients) are
limited, more metabolic genes are essential than in the
rich medium. Hence, gene deletion studies with minimal
media predicted 25% more essential genes than in the
case of enriched environments. These genes are condi-
tion-dependent lethals [18] and are based on the specific
growth environment. Condition-independent lethal
genes are those that are lethal irrespective of the envir-
onment. Unconditional essential genes were identified
for iRS605 at the intersection of the sets of such essen-
tial genes in six environmental conditions including a
simulated macrophage environment.
Based on this intersection set we found 105 condition
independent lethal genes (Additional File S4). Given the
scarcity of experimentally confirmed essential genes dur-
ing infection with Francisella, we used data on virulence
genes associated with metabolism to determine if our
predictions matched any existing literature
[19-21,21-24,23,25-31,22,32-34,34,35]. The identification
of genes essential for survival not only suggests potential
virulence genes, but is also important for understanding
the minimal requirements for pathogen survival in the
host cell. The model predicted essential genes involved
in virulence with 47% accuracy (Table 1). Such single
gene perturbation experiments are effective in identify-
ing components in Francisella that are essential for the
growth phenotype and whose deletion may cause
attenuation in pathogens.
Metabolic reactome during infection
The metabolic capacity of an organism is determined by
all available alternate routes it can use to achieve its
growth objective. As demonstrated for Salmonella,f o ra
pathogen it is the ability to achieve this during infection
[5]. Flux variability analysis (FVA) was used to identify
such metabolic reactions that might be operational in
different environments including that during infection.
This allows us to identify the host metabolism that
Francisella could exploit in order to survive and
replicate.
In defined medium (Chamberlain with glucose) 32% of
the network reactions that span a range of flux values
when biomass production was optimal were operational.
The constraining conditions that represent the environ-
ment during infection in the macrophage (Additional
File S3) were derived by literature mining. Based on this
nutrient composition, FVA identified only 103 reactions
that can be utilized for growth via alternate routes. This
s u g g e s t st h a to n l y6 %o ft h ew h o l eg e n o m e( e q u i v a l e n t
to 17% of the metabolic network in iRS605) spans a
non-zero integer flux for optimal biomass production.
This is less than half of that we found in silico for
Salmonella iRR1083 in a similar environment [5].
Table 1 Comparison of predicted in silico virulence with
experimentally determined in vivo virulence
LVS locus Schu4 locus Gene Virulence
in silico in vivo
FTL_1071 FTT_1019c guaA + +
FTL_1478 FTT_1317c guaB + +
FTL_0395 FTT_0893 purM + +
FTL_0396 FTT_0894 purCD + +
FTL_1504 FTT_0721c katG - +
FTL_1791 FTT_0068 sodB - +
FTL_0483 FTT_0413c glgB - +
FTL_1262 FTT_0945 + +
FTL_0838 FTT_1124 metN + +
FTL_0837 FTT_1125 metIQ + +
FTL_0789 FTT_1165c aspC2 - +
FTL_0606 FTT_1450 wbtM - +
FTL_0594 FTT_1462c wbtC - +
FTL_0592 FTT_1464c wbtA - +
FTL_0304 FTT_1490 - +
FTL_1701 FTT_1631c gplX - +
FTL_0058 FTT_1168 + +
Accuracy of iRS635 virulence prediction = 47%
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pathways during infection. The larger reactome (equiva-
lent to 37% of iRS605) during optimal growth in a mini-
mal medium (Chamberlain with glucose) supports this
hypothesis. The condition-independent reactome
for optimal growth identified 59 reactions (Additional
File S5).
We compared the transcriptomic data from literature
[36] and found that 33% of the genes are contained in
the optimal reactomes under the same conditions in
silico (Additional File S5). Proteomic data [37] identified
171 metabolic proteins by iTRAQ. 52% (89) of these
proteins were detected in silico (Additional File S5). The
prediction of metabolic capacity as a function of the
reactome is lower for Francisella than for Salmonella
[5] (77% ad 98% accuracy for transcriptomic and proteo-
mic data respectively). A reduced metabolic genome
increases dependency on availability of nutrients and
necessary metabolites that cannot be made in the cell.
The accurate representation of this environment is cru-
cial in determining the predictive capability of iRS605.
The lower predictive capability of the model in compari-
son to Salmonella is in part due to the incomplete
knowledge of exchange fluxest h a tr e p r e s e n tt h ee n v i r -
onment during intracellular replication and infection
and in part a result of Francisella’s unique potential to
exploit of the host niche for intracellular replication and
growth.
Effect of constraining metabolite flux and gene
expression levels on growth
The effect of reducing expression levels of metabolic
genes on growth was tested in silico using robustness
analysis [38]. Pair-wise interrogation of growth as a
function of varying expression of the metabolic genes
(studied during infection) was conducted in different
environments. Among the genes studied 25% of them
were observed to have a differential effect on growth
rate under in vivo and in vitro conditions. Robustness
diagrams (RD) consist of trajectories describing the lin-
ear or non-linear relation between a specific metabolic
enzyme concentration (correlated here to mRNA abun-
dance) and growth.
One particularly striking example of the power of in-
silico simulation is the investigation of pH homeostasis
on cell behavior. In the case of Francisella grown in
Chamberlain medium the presence of amino acids and
their consumption could compensate for excess pro-
tons by production and exchange of ammonium (NH4
+) ions in the opposite direction. Thus media might
serve as pools supplying and dissipating both acidic
and basic ions as needed. The calculated ammonium
flux out of iRS605 is four times that of Salmonella.
The model was used to correlate the effect of changing
H
+ and NH4
+ ion flux on growth rate in different
environments using robustness analysis (Figure 2). The
effect on growth rate was highly dependent on the
media composition. Completely distinct trajectories
were observed in each case.
In the absence of any added carbohydrate source in
Chamberlain media, the RDs for NH4
+ and H
+ ions
are complex and consist of multiple trajectories and
inflection points. Initially, the H+ ion trajectory has a
negative slope and although fluxes move on same time
scales, they are in opposite direction. This implies low-
ering of growth rate as H+ ion flux increases. This is
accompanied by a simultaneous increase in NH4
+ flux
(positive slope on the trajectory I of NH4
+ RD) that
might neutralize the environment to promote growth.
The RDs for both ions show a threshold above which
there is a sharp decrease in growth rates. Thus there
exists a limiting concentration of these ions that
results in a buffered environment ideally suited
for growth of Francisella. In the presence of glucose
(2 mg/ml) in Chamberlain media both NH4
+ and H
+
ions lower the growth rate gradually. During infection
of host cells the growth seems to be independent of
the NH4
+or H
+ ion fluxes. This type of analysis
demonstrates the power of our systems approach to
generate important new hypotheses that can then be
addressed experimentally.
Metabolic profiling of Francisella
Metabolic profiling of Francisella was done to identify
carbon and nitrogen sources (C/N) that it can utilize for
respiration. Different growth states of Francisella were
tested to identify changes in metabolic capacity based
on age and growth cycle. Cells were pre-cultured on
rich chocolate agar plates to confluence and minimal
Chamberlain media with glucose to exponential, mid-
log, and stationary phase.
Cells in early exponential phase or chocolate agar
grown cells were able to utilize a vast array of C/N
sources (Figure 3). 60% (57/96) of substrates were uti-
lized which is similar to that observed for several other
isolates of Francisella as reported in literature [39]. Cul-
turing on chocolate agar reduced the ability to utilize
22% of the carboxylic acids utilized otherwise (Figure 3).
Cells in stationary phase lost the ability to respire on
most C/N sources (Figure 3). Irrespective of the growth
p h a s et h e ya r ei n ,Francisella cells can utilize 10 com-
pounds including some hexoses and amino acids com-
pletely and 8 compounds including glycoconjugate and
pyrimidine salvage intermediates partially for respiration
(Figure 3). Although the model could predict steady-
state growth accurately for about 50% cases, it currently
cannot predict the switch in carbon utilization patterns
due to growth phase induced by regulatory effects.
Raghunathan et al. BMC Systems Biology 2010, 4:118
http://www.biomedcentral.com/1752-0509/4/118
Page 6 of 19Differential effect of carbon sources on bacterial growth
Chamberlain’s chemically defined medium with the
addition of different sugars was used to experimentally
determine the growth and metabolism of Francisella.
The same media composition was also used to compute
the state of Francisella cells in silico for validation and
predictive purposes. Considerable growth was observed
on all carbon sources tested as seen in the growth
curves (Figure 4A). Growth followed Monod kinetics on
all investigated carbohydrates. F. tularensis was also able
to grow in Chamberlain media on amino acids without
an additional carbohydrate source. Increasing the amino
acid concentration increased the growth rates as has
been reported [40,41]. However, the specific growth
rates were slower and the final biomass concentration
was much lower (Figure 4B). When we studied the
effect of the concentration of glucose on specific growth
rates we found an increase in growth rates with increase
in glucose concentration with a sudden jump at 1 mg/
ml (0.1% wt/vol), the physiological concentration of
glucose). Growth on the selected hexoses glucose and
fructose allowed similar uptake and growth rates, while
the pentoses xylose and ribose resulted in lower growth
rates and biomass yields. HPLC analysis of the spent
media showed complete consumption of all amino acids
added to the medium (data not shown). This confirmed
an earlier prediction of the model that amino acids can
fulfill the bulk requirement for growth, although addi-
tional carbohydrates are needed to achieve better bio-
mass yields. Using FBA we were able to predict the
experimentally determined growth rates accurately (Fig-
ure 4C). The corresponding uptake rates of all the com-
pounds that define the media composition are
represented as exchange fluxes in silico. The saturation
constant (Ks = 0.5 mg/ml) and maximum growth rate
(μmax0.4 hr-1) on glucose were estimated using the
experimental data. Using the model to vary initial
uptake rates of glucose and to estimate growth rate
resulted in a good correlation between experimental and
in silico results.
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Figure 2 pH homeostasis predictions by Francisella model iRS605. Robustness diagrams depict the effect of proton flux and ammonium ion
flux on growth rates of Francisella as a function of the environment. Left panels show H+ ion effects, while the panels on the right show NH4+
ion effects. Distinct trajectory types are observed in all media. Media used were Chamberlain minimal medium (Chamberlain), Chamberlain
medium supplemented with glucose (Chamberlain +glu), and host cell conditions (as described in Additional File S3).
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specific growth rates lower by an order of magnitude
(Figure 4D). Oxygen conditions are simulated by speci-
fying a value for the uptake rates of oxygen (defined as
exchange flux EX_O2 in the model; see constraints in
Additional File S1). The model also predicts an order of
m a g n i t u d ed e c r e a s ei ng r o w t hr a t eo nd e c r e a s i n gt h e
oxygen uptake rates (OUR) from 100 to 0.1 mmol/
gDCW/hr on all the carbohydrates tested. Our values of
less than 4 mmol/gDCW/hr have been observed for sev-
eral organisms [42,43] under microaerobic conditions.
Anaerobic conditions were simulated using a zero oxy-
gen uptake rate.
Gene expression profiling
The global metabolite pool in the macrophage cytosol
defines the substrate availability and nutrient milieu for
Francisella. Variations in gene expression of metabolic
pathway genes reflect changes in components of this
pool as the pathogen adapts to the host environment.
We selected a core set of 69 metabolic genes for quanti-
tative analysis (Additional File S6), which included genes
that may be required for adaptation to the host cell by
driving metabolism, energy and pH homeostasis. These
genes included some house-keeping genes and genes
with putative predicted function.
Initially we analyzed the expression of selected meta-
bolic genes during growth under defined culture condi-
tions (Figure 5A) in order to gain insight into the use of
metabolic pathways that might correlate to Francisella’s
intracellular growth. Gene expression was measured
quantitatively by using the Genomelab Expression profi-
ler (GeXP) as described in Methods. The media and
other physical parameters were kept identical except for
carbohydrates added to the medium. During growth on
all carbohydrates, the citrate synthase gene, glucose-6-p
isomerase, NAD dependent malic gene, pyruvate kinase,
isocitrate dehydrogenase, NADH dehydrogenase, choris-
mate synthase, fructose 1,6 bisphosphatase, glucose
kinase, purine/pyrimidine phosphotransferase, glutamine
synthase were all active indicating similar metabolic
function and up-regulation of central metabolic, amino
acid, and nucleotide pathways. However, some of the
specific substrate utilizing, amino acid, nucleotide meta-
bolism, and transport genes had different expression
profiles, depending on the added carbon source. In the
case of growth on pentoses and glycerol, glycolysis and
TCA cycle genes (phosphoglucomutase, succinate dehy-
drogenase, bdII cytochrome oxidase and others) were
low (two-fold) compared to growth on hexoses. During
growth on pentoses and glycerol, the expression level of
the glycine cleavage system (H-protein) was 2-fold that
found for hexoses. There was also a 2-fold increase in
PEP carboxylase (converts PEP to oxaloacetate)
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Figure 3 Metabolic profiling of Francisella in different growth
phases. Bacteria were grown overnight on agar or in Chamberlain
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Figure 4 Experimental and in silico growth characteristics of Francisella on carbohydrates. A. Growth curves of Francisella follow monod
kinetics. Cells were grown in Chamberlain medium supplemented with the respective carbon source as indicated (FRU; fructose, ARA: arabinose,
XYL: xylose, RIB: ribose, GLY: glycerol, GLU: glucose). Optical density (600 nm) was measured every 120 minutes. B. Final biomass yields on
different carbon sources. Cells were grown in Chamberlain medium supplemented with carbon sources as in A. Yield is expressed in dry cell
weight (DCW). C. Comparison of growth rates in Chamberlain media supplemented with carbon sources as indicated were determined
experimentally and calculated in silico under aerobic conditions. Specific growth rates on glucose were used to determine the Um and Ks
values. D. Growth rates in Chamberlain medium supplemented with carbon sources as indicated were determined experimentally and calculated
in silico under microaerobic conditions. Robustness analysis using iRS605 depicts aerobicity based on ranges of oxygen uptake rates and the
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Figure 5 Selected metabolic transcriptome of Francisella in varying environments.A .B a c t e r i aw e r eg r o w ni nC h a m b e r l a i nm e d i u m
supplemented with carbon sources as indicated (Fru: Fructose, Ara: Arabinose, Xyl: Xylose, Rib: Ribose, Gly: Glycerol, Glu: Glucose, C: Chamberlain
media only). Expression of 75 selected metabolic genes was measured using RT-PCR and GeXP (described in detail in Materials and Methods).
Data were normalized to the house-keeping gene FTL_001 and are presented relative to expression in glucose media. B. Macrophages were
infected with Francisella for 1 h and for 24 h. Expression of selected metabolic genes was quantitatively measured as described in A. Data were
normalized to the house-keeping gene FTL_001 and are presented relative to gene expression in macrophage 1 h after infection. C. Composite
Heat Map of the selected Francisella metabolic transcriptome. Data from A and B were clustered based on environments and functional
categories of the genes.
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Page 10 of 19expression. Relatively higher rates (2 fold increase) of
aromatic amino acid synthesis (shikimate kinase, anthra-
nilate synthase) also took place when Francisella was
growing at the expense of fructose and glycerol as car-
bon-sources. PRPP synthesis was similar in all cases,
suggesting similar rates of nucleotide biosynthesis. How-
ever, during growth on glycerol adenine phosphoribosyl
transferase was very low, suggesting the de-repression
by FBP. On comparison with the data where no carbo-
hydrate was added to Chamberlain media, amino acid
pathway genes were expressed at higher levels than
genes involved in the metabolism of fatty acid oxidation
(FAX), oxidative stress response (OX), and gluconeo-
genesis (GNS).
Gene expression profiling during Francisella infection
We then measured gene expression of selected meta-
bolic genes in Francisella recovered from macrophages
after one or twenty-four hours of infection (Figure 5B)
and compared those to the profiles obtained when Fran-
cisella was grown in defined culture media.
Several genes of the citric acid cycle were expressed,
including succinate dehydrogenase and cytochrome bdII.
The data showed a glutamate decarboxylase mediated
pH homeostasis in Francisella within an hour after
infection. ATP synthesis and simultaneous proton
exchange was mediated by F1F0 ATP synthase
(increased expression) and was required for acid resis-
tance and is critical to survival in the host cell. The
pathogen respires oxidatively in the initial stages as indi-
cated by increased ubiquinol oxidase activity. Expression
of ubiquinone/menaquinone biosynthesis gene in later
stages was detected, suggesting a switch to more micro-
aerophillic environments. Co-expression of glycolysis/
gluconeogenesis (phosphoglycerate kinase and glyceral-
dehyde phosphate dehydrogenase) and fatty acid oxida-
tion genes at this time indicated the switch in carbon
source utilization for growth and survival in the macro-
phage. The gene encoding PEP carboxykinase was highly
expressed at 24 hr post infection. Our data also show
the utilization of fatty acids as growth substrates, similar
to what has been observed for Mycobacteria [44]. Sev-
eral genes involved in the beta-oxidation of fatty acids
were seen to be upregulated including a ligase that has
been implicated in import of exogenous fatty acids. This
is not surprising since fatty acids are the preferentially
utilized gluconeogenic substrates during carbohydrate
limiting conditions. Anaplerosis seems to be mediated
by PEP carboxykinase, which was upregulated in Franci-
sella, and also by increased expression of several other
genes involved in oxaloacetate synthesis. Detection of
catalase and peroxidase early on in Francisella suggests
a redox active phenotype for the macrophage. Amido
ribosyltransferase (AMPRT), which commits pentose
phosphate pathway metabolite PRPP to nucleotide bio-
synthesis, had increased mRNA abundance but there
were lowered transcript levels for adenine phosphoribo-
syltransferase (APRT) at 24 hours post infection. This
might result in AICAR accumulation, which is an allos-
teric regulator for many pathways. These data demon-
strate the metabolic adaptations Francisella undergoes
when replicating in macrophages.
We also observed upregulation of amino acid genes
(anthranilate synthase I, chorismate mutase II), sugar
metabolism genes (glyceraldehyde-3-phosphate dehydro-
genase, phosphoglycerate kinase) and genes related to
fatty acid metabolism (phospholipase D and acid phos-
phatase precursor). This suggests a possible intra-
macrophage environment for pathogen metabolism
during infection. The up-regulation of both acetyl-coA
carboxylase subunits indicates regulation of fatty acid
oxidation by synthesis of malonyl-coA. The down-regu-
lation of PEP carboxykinase indicates that there may be
other mechanisms of mediating anaplerosis during
infection.
Figure 5C summarizes the patterns of gene expression
as a composite heat map for carbon source assimilation
and energy production leading to growth of Francisella
in the macrophage and in vitro. Hierarchical clustering
analysis (based on Pearson coefficients) showed similar-
ity when Francisella was grown on the pentoses (xylose
and ribose) or on the hexoses (fructose and glucose)
studied. Expression profiles on glycerol resembled that
on pentoses. Gene expression levels during growth on
arabinose were distinctly different. Gene expression pro-
files during infection resembled those during growth on
defined media with pentoses as carbon sources. Cluster-
ing based on genes also showed that genes were
expressed similarly based on functional category.
Gene expression profiles and robustness of iRS605
The model predictions of robustness analysis matched
the trends in differential gene expression both in vivo
and in vitro. Among the genes whose expression levels
do not affect the growth differently based on environ-
ment, are the nodes of metabolic network that are
highly connected, like ATP synthase and NADH dehy-
drogenase (Figure 6A). The reactions catalyzed by the
genes whose expression levels affect growth rate (regu-
l a t e db ye n v i r o n m e n t )a n dt h o s et h a ta r en o tr e g u l a t e d
are listed in Figure 6A. The genes whose level of expres-
sion affect the growth rate include genes of core central
metabolism including nucleotide, acid resistance, carbo-
hydrate functional classes. Figure 6B shows the effect of
varying the effect of one such gene involved in Gluta-
mate/GABA antiport on growth in varying environ-
m e n t s .T h eg r o w t hr a t ea n dG A B Aa n t i p o r tf l u xa r e
separated by different time scales both in vivo and in
Raghunathan et al. BMC Systems Biology 2010, 4:118
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citrate synthase fructose-1,6-bisphosphate aldolase
NAD-dependent malic enzyme glucose-6-phosphate isomerase
GlpX- fructose 1,6-bisphosphatase II glutathione synthetase 
pyruvate kinase glutamate decarboxylase
glucose kinase isocitrate dehydrogenase
phosphoenolpyruvate carboxykinase g-3-p dehydrogenase
acyl-CoA dehydrogenase phosphogylcerate kinase
peroxidase/catalase glutamate/gamma-aminobutyrate  anti-porter
phosphoglucomutase putative arginine decarboxylase
phosphoenolpyruvate synthase adenine phosphoribosyltransferase 
glutathione peroxidase  amidophosphoribosyltransferase
NADH dehydrogenase I, H subunit  aspartate carbamoyltransferase
chorismate mutase  bifunctional proline dehydrogenase
cytochrome o ubiquinol oxidase subunit II pyrroline-5-carboxylate dehydrogenase
cytochrome oxidase bd-II, subunit II Glyceraldehyde-3-phosphate dehydrogenase
chorismate synthase phosphogylcerate kinase
glutamine synthetase glycine cleavage system H protein
branched-chain AA aminotransferase protein acid phosphatase (precursor)
ATP synthase beta chain 
succinate dehydrogenase, cytochrome b556
purine/pyrimidine phosphoribosyl transferase 
menaquinone biosynthesis methyltransferase
anthranilate synthase component I 
ATP synthase alpha chain
shikimate kinase
anthranilate synthase component II 
superoxide dismutase [Fe]
Fructokinase
anthranilate synthase component I
chorismate mutase II
Acetyl-CoA carboxylase beta subunit
biotin synthase
anthranilate synthase component II
chorismate mutase I
acetyl-co A carboxylase carboxyl transferase
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Page 12 of 19vitro. In vitro (Chamberlain media) the addition of a
carbohydrate changed the robustness diagram trajectory.
I ft h ef l u xt h r o u g ht h eG A B A / G l u t a m a t ea n t i p o r t e ri s
equated to the observed mRNA abundance in vitro,t h e
growth rate is in the maximum range in silico,i n d i c a t -
ing the time of harvest in exponential growth. The
homolog of this gene in E.coli forms a part of the gluta-
mate based acid resistance system that protects E.coli
from the deleterious effects of high proton concentra-
tion environments [45].
Discussion
Metabolism of the pathogen during infection of its host
is one of the most fundamental aspects of the host-
pathogen relationship. Emphasis on mechanisms and
survival strategies aimed at evading the immune
responses of the host often ignore that the host cell
determines the habitat for the pathogen by limiting con-
centrations of certain nutrients and other essential
metabolic factors. The pathogenicity of F. tularensis has
been linked to the ability of the pathogen to escape
from the phagosome and replicate in the cytosol [46].
Little is known about central metabolic, amino acid,
fatty acid, and nucleotide pathways used by F. tularensis
during infection. This is the first comprehensive study
that uses a systems biology approach to define the meta-
bolic capacity of an experimentally ill-characterized
pathogen, F. tularensis, in multiple environments includ-
ing the macrophage cell. In this study we designed an
in silico strain iRS605 of Francisella tularensis LVS and
used it to probe the functional state of the cell.
Francisella represents a pathogen with limited experi-
mental datasets and has recently garnered increased
attention because of its potential as a biothreat agent.
Our systems approach presented here illustrates how
constraints-based computational analysis can be used
under these circumstances in an efficient way to provide
an analysis of the pathogen’s metabolic potential during
infection and provide a framework for integration of
high-throughput datasets. Such an approach is an
important testing ground when novel therapeutics or
vaccines have to be developed for an emerging pathogen
for which initially only high-throughput data such as
genomic and transcriptomic data are available.
Francisella has a reduced genome although about a
quarter of its genome codes for metabolic functions.
Only the penultimate or final steps of many metabolic
pathways, such as those of amino acid biosynthesis, are
maintained in the pathogen. It has a broad range of host
specificity, which suggests that its metabolism is specifi-
cally tailored to exploit conserved eukaryotic metabolic
niches. Thus there may have been a certain selection
pressure during the evolution of Francisella to select or
preserve enzymes with a broader specificity and
subsequently reduce genome size and still be an inimita-
ble intracellular pathogen. This is supported by flux bal-
ance analysis of iRS605, which demonstrates very
stringent growth requirements, and by in silico gene
deletion analysis, which predicts a high number of 105
condition-independent single essential genes.
Experimental single gene deletion assays have become
a principal established tool for studying cell behaviour
[5,47,18]. Such experiments, however, are not trivial for
class A biothreat agents or for uncharacterized novel
pathogens, for which genetic tools and suitable screen-
ing assays are not readily available. At the same time,
gene deletion data are essential for understanding
pathogenesis and, more importantly, for identifying
potential targets for antibacterial intervention. Our stu-
dies here demonstrate how a genome-scale metabolic
reconstruction can very efficiently generate a list of
lethal single gene deletions using appropriate con-
straints. The distribution of essential genes into func-
tional categories shows that most belong to amino acid
(22%) and nucleotide (21%) metabolism. The other func-
tional categories that feature in this list include fatty
acid/lipid metabolism (12%), cell wall synthesis (19%),
cofactor biosynthesis (18%), and extracellular transpor-
ters (4%). Only 4% of genes involved in carbohydrate
metabolism (all part of the reductive pentose phosphate
pathway branch) were identified as essential for the sur-
vival of Francisella. The significance of amino acid
metabolism is also supported by our experimental data
that demonstrate that all amino acids in Chamberlain
media are consumed in the presence of a carbon source.
Asparagine, tryptophan and glutamine synthase genes
are essential probably because only their precursors are
available to Francisella in the host cell. Amino acid dec-
arboxylases may coordinate pH homeostasis along with
their corresponding antiporter. Nucleotide metabolism
genes are indeed critical to the survival of the pathogen
with PRPP being supplied by the pentose phosphate
pathway. The production of several intermediates in
purine and pyrimidine synthesis is essential and suggests
a role as substrates for other networked pathways. Inter-
conversion of nucleotide kinases is important since all
the four nucleotide kinases are predicted to be essential.
Several fatty acid genes are also essential and suggest
the use of fatty acids as gluconeogenic substrates. Com-
bined with limited validation by transcriptomic profiling
as presented in this study this approach can thus gener-
ate testable hypotheses. These will have to be validated
by further experimentation, but our approach signifi-
cantly reduces the possible solution space. We have also
illustrated this approach by highlighting how the
in silico analysis of pH homeostasis affects the metabo-
lism and subsequently growth of Francisella, which cor-
relates well with observed experimental results.
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nodes in metabolic networks that act as potential con-
trollers of overall metabolism. One such example is
AICAR. The adenylyosuccinate lyase gene that catalyzes
its formation, is a condition independent lethal gene,
essential for survival. Robustness analysis showed that
flux through the adenylosuccinate lyase and AICAR for-
myltransferase genes need to be in equilibrium for opti-
mum growth (production and consumption of AICAR
must be at steady state). AICAR is a known allosteric
regulator of several enzymes in carbohydrate and amino
acid metabolic pathways [48]. AICAR is also known to
stimulate beta-oxidation and drive the equilibrium of
FBP towards gluconeogenesis. Fatty acid utilization for
gluconeogenesis during infection is also supported by
increased AICAR synthesis, which is known to stimulate
beta-oxidation. mRNA transcript data in Chamberlain
media supplemented with glycerol and glucose also sug-
gest an accumulation of AICAR as a regulator of
fructose bis phosphatase (fbp) gene in Francisella. Thus,
the predicted accumulation of AICAR in the macro-
phage suggests a role as a potential master regulator
during infection. Such hypotheses are not readily intui-
tive and further demonstrate the usefulness of a systems
biology approach (Figure 7).
Our in silico analysis was able to demonstrate that
Francisella undergoes changes of its metabolism when it
enters its host. Flux variability analysis determines all
possible alternate routes for growth of a bacterium that
are necessary under specific conditions. iRS605 would
thus be able to achieve this objective with a smaller
reactome in nutrient rich conditions than in a minimal
medium in silico. The common reactome of Francisella
during infection and during growth on Chamberlain
medium with glucose (Additional File S5) is comprised
of genes required for growth and macromolecule forma-
tion including nucleotides and fatty acids. The microbe
tends to utilize preferentially specific amino acids for
Figure 7 Systems Biology approach to novel non intuitive hypothesis generation and testing. Identification of AICAR as a potential
master regulator in infection as result of combining multiple diverse data types in the context of a stoichiometric model. FBA can be used on
the derived model for Francisella to calculate the functional state and identify AICAR as key node.
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than relying on carbohydrate sources like glucose and
fructose during infection. These predictions have been
validated by selective quantitative gene expression profil-
ing as discussed earlier. The significance of these find-
ings remains to be further elucidated, especially in
conjunction with further research as to what particular
metabolic niche the host provides and how it might deal
with intracellular pathogens by restricting the availability
of certain nutrients. Previous metabolic analysis of the
model pathogen Salmonella [5], which displays greater
variability of its metabolic pathways during intracellular
growth, revealed alternate functional pathways that are
operational during infection. Models and data for both
organisms, however, demonstrate a robust limited set of
reactions required for intracellular proliferation. Thus, a
systems biology approach as presented here reduces the
possible solution space for novel antibacterial targets.
Constraints-based modeling approaches have now
been used for a variety of prokaryotic and eukaryotic
organisms, but usually for those with a significant body
of experimental data. In most of these cases the model-
ing efforts could predict experimental findings with
some accuracy and correlated with prevailing hypotheses
about pathogenesis. In Mycobacterium tuberculosis con-
straints-based modeling was also used to predict poten-
tial targets for antibacterial therapy in the mycolic acid
pathways, which has always been the main attention of
antituberculous research [49]. The challenge in patho-
gens which have not been extensively studied but which
may gain rapid notoriety due to intentional release into
the population or due to sudden unanticipated epidemic
spread, is the rapid identification of Achilles heels that
can be exploited for intervention. Our studies here
demonstrate that constraints-based modeling might
significantly aid such efforts.
Conclusions
We have presented here the reconstruction of a gen-
ome-scale metabolic model for the biothreat agent Fran-
cisella tularensis (iRS605). This model has been
validated by legacy data, experimental phenotypic arrays,
selective determination of metabolites, and growth pro-
files on defined minimal media. We demonstrated an
accuracy of almost 80% in predicting growth and viru-
lence phenotypes.
Analysis of the model showed significant changes of
metabolism during Francisella’s intracellular growth in
its host cell, the macrophage. This was evident in a
switch from oxidative metabolism (TCA cycle) in the
initial stages of infection to glycolysis, fatty acid oxida-
tion, and gluconeogenesis during the later stages.
Computational analysis also demonstrated a limited set
of metabolic genes that are likely to be operational
during infection. These findings were corroborated by
quantitative gene-expression profiling of selected genes
that code for key metabolic enzymes. Prediction of
synthetic lethals also identified a set of potential drug
targets.
We have thus demonstrated how such an integrated
systems approach can be used for pathogens with lim-
ited extended datasets to elucidate key metabolic pro-
cesses during pathogenesis and identify potential novel
drug targets.
Methods
Metabolic Reconstruction
Reconstruction and model development of the metabolic
network followed established methods [5,3]. The recon-
struction process and the contents of the iRS605 are
summarized in Additional File S1. The reconstruction
process was done using SimPheny™ (Genomatica, Inc.,
San Diego, CA), a platform for cellular model develop-
ment, which includes an interface for references, anno-
tation, and confidence levels of annotation. The
sequence based genome annotation of F. tularensis
subsp. holarctica ( GenBank Accesion AM233362.1) was
downloaded and served as the framework for the initial
draft of reconstruction. Charge and elementally balanced
reactions were added individually based on this annota-
tion and legacy data when available. Biohealthbase and
FranTCyc were used as ancillary tools. Following the
initial reconstruction, the gaps were evaluated individu-
ally by searching for direct evidence in the literature for
their metabolism. Due to the relative paucity of litera-
ture for F. tularensis, many of these gaps could not be
filled. Legacy data in the form of primary articles, review
articles, and textbooks were employed in addition to the
database resources during the reconstruction and model
building phases. If an annotation was made to an ORF
that supplemented the annotation found in the genome
file or that led to additional functional assignments, this
was noted in the reaction database for the model in
Simpheny. Also, high sequence homology of an ORF in
the LVS strain, compared to genes in other species of
francisella with strong experimental evidence were
included in the model. A comprehensive map of iRS605
metabolic network was visualized by creating a map of
the network organized by lumped subsystems of meta-
bolism. After the debugging process, when the cell
could grow (i.e. produce biomass) on different media,
the remaining intracellular gaps were evaluated by
searching the literature for evidence of metabolic reac-
tions involving that particular metabolite in different
species of the bacterium. If no evidence of transport or
biochemical transformations of the metabolite in
F. tularensis was found, no additional reactions or trans-
porters were added.
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A reaction that represents biomass production is
included in the model to account for the drain of pre-
cursors and macromolecular building blocks into bio-
mass. Biomass was represented as a linear combination
of all the macromolecular components (lipid, glycogen,
lipopolysaccharide, and peptidoglycan) or monomers of
macromolecules (amino acids and nucleotides). Amino
acid and fatty acid composition were experimentally
measured (data not shown) using standard methods [5].
The relative fatty acid composition was used to specify
the average fatty acid content on the phospholipds and
diacylglyerol. F. tularensis data from the literature was
then used to determine the amount of lipids (and their
phospholipid composition), lipopolysaccharide, peptido-
glycan, and glycogen. The stoichiometric ratios of all the
components in biomass are given in the non-gene asso-
ciated reaction in Additional Files.
The growth associated ATP maintenance was calcu-
lated using data from Figure 4 and Flux Balance Analay-
sis (FBA). The measured fluxes were set as constraints
and FBA was used to calculate the maximal amount of
ATP that could be generated. The resulting ATP pro-
duction reflects the amount required for growth and
maintenance, additional to the ATP required for precur-
sor biosynthesis. When the maximal ATP production
rate is plotted against growth rate, the intercept gives
the maintenance coefficient (in mmol h
-1 gDW
-1:9 5 ) ,
and the slope gives the amount of ATP (in mmol gDW
-
1) required for assembly. The high ATP value is indica-
tive of less energetically efficient pathway usage. The
model will always use the reactions that give the highest
P/O ratio. If the organism uses instead, a less energetic
enzyme systems, then the ATP terms would be lower
because of a forced lower P/O ratio. This is similar to
organisms like Lactobacillus and Shewanella species
(Jennifer Reed, unpublished results). The biomass reac-
tion thus represents the weighted combination of com-
ponents forming the dry weight of the cell and the
amount of ATP hydrolysis, needed for energy during
growth and cellular maintenance as discussed.
Constraint-based modeling
The reconstructed metabolic network was represented
by a stoichiometric matrix, S (m × n), where m is the
number of metabolites and n is the number of reactions.
Reactions within the network were mass balanced such
that Sv = 0, where v was a steady-state flux vector.
Additional constraints (like media composition, gene
expression data) on each reaction had the form i vi ßi,
where i and ßi represented the lower and upper limits,
respectively. i was set to zero for irreversible reactions,
whereas ßi was set to measured uptake rates for
transport reactions or the Vmax of the corresponding
enzymes.
The biomass reaction thus represents the weighted
combination of components forming the dry weight of
the cell and the amount of ATP hydrolysis, needed for
energy during growth and cellular maintenance as dis-
cussed elsewhere.
Flux Balance Analysis
Fluxes through metabolic reactions across the network
can be calculated using flux balance analysis (FBA).
With FBA, the biological system is assumed to be at
steady-state so that all intracellular metabolite concen-
trations and fluxes are assumed to be constant. The
steady-state assumption makes it possible to compare
the simulation results directly to data obtained from
cells growing at a fixed growth rate. FBA is formulated
as an optimization problem, where constraints are
imposed that limit flux values (steady-state mass balance
constraints and upper and lower bounds for fluxes
based on thermodynamics and substrate uptake con-
straints). These constraints define the range of values
that fluxes can take. An objective function is also used
to compare flux distributions (v) that satisfy all the con-
straints in order to find optimal flux distributions. Flux
through the biomass production reaction has success-
fully been used as an objective function for E. coli
(along with other objective functions) [50] and was also
used for FBA performed in this study. Thus, FBA pre-
dicts an optimal growth yield and a flux distribution(s),
which correspond to this maximal growth yield. Alter-
nate optimal solutions exist, and flux variability analysis
was additionally used to identify the ranges individual
fluxes can take while still achieving the maximal growth
yield. Reaction flux, is measured in mmol/h/g (dry
weight), and the growth rate was reported in units of 1/
h. Ammonia exchange fluxes were estimated using flux
balance analysis. The effect of various other parameters
on ammonium flux was calculated using robustness ana-
lysis. The objective of the model (in silico cell) was
growth and the constraints were set to represent the
environmental conditions and the flux through the
ammonium exchange reaction was calculated using
linear optimization at steady state.
Robustness Analysis
Robustness analysis is performed by varying a particular
flux through a pre-defined range and recalculating the
objective function. The slope of the curve describes the
sensitivity of the objective function on that particular
flux (over the specified range of values). The flux
through several reactions in the metabolic network was
varied and the growth rate was calculated.
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Two different environments were used to provide con-
straints for simulations: (i) Chamberlain minimal med-
ium (contains 13 amino acids in addition to salts,
phosphate, sulfate, ammonium minerals) with a variable
carbon source [11]; (ii) host-cell nutrient environment
(representing nutrient conditions inside a host-cell dur-
ing infection). While the host-cell nutrient environment
was difficult to ascertain, it was based on an extensive lit-
erature review to identify a possible composition [5].
Details of all simulated media conditions are provided in
Additional Files (S3). Additional File S1 shows how
media composition is represented as exchange fluxes to
use as constraints in the model. For simulation of aerobic
growth, the following external metabolites were allowed
to freely enter and leave the network: phosphate, ammo-
nium, sulfate, water, oxygen, and proton. All metabolites
that were not media components (potential products)
were only allowed to leave the system.
Growth and Infection Experiments
F. tularensis LVS strain was used for all experiments.
LVS was grown in Chamberlain media. Chamberlain
media was supplemented with 4 mg/ml of the following
sugars: glucose, glycerol, fructose, arabinose, ribose, and
xylose. All in vitro growth experiments were done in an
incubator shaker at 37°C and 150 rpm. Samples were
withdrawn every 2 hours and the optical density (OD)
measured. OD was correlated to dry weight using a pre-
viously determined calibration curve (y = 0.74 ×). Sam-
ples were further syringe filtered and centrifuged in
order to obtain supernatants for HPLC analysis. Infec-
tion of the macrophage-like cell line RAW264.7 was
performed as described previously [51].
HPLC Analysis
Organic acid and sugar analysis was done using an ion
exchange Aminex 87H
+ column (Biorad). A 5 mM Sul-
furic acid mobile phase at a flow rate of 0.5 ml/min at
65°C was used for separation. Both UV and RI (refrac-
tive index) detector were employed. Small molecules
were quantified using previously determined calibration
curves.
Amino acid analysis was performed using a Waters
AccQTag column. Samples were derivatized using the
kit and the protocol recommended to form a 6-amino-
quinolyl-N-hydroxysuccinimidyl carbamate derivative of
the amino acid. The derivatized amino acids were then
separated and detected using the C18 reverse phase
AccQ-Tag column, with a flow rate of 1 ml/min at 37°C
using a 12.5 mM sodium phosphate: Acetonitrile mobile
phase with a previously published gradient profile. UV
detection was employed and the amino acids were quan-
tified using previously determined calibration curves.
Metabolic phenotyping
Metabolic profiling was performed using GN2 plates.
(Biolog, Inc). Protocols provided by the manufacturer
were followed. For experiments determining the effect
of growth state on metabolic phenotype, Francisella was
harvested at different growth phases. Early exponential
phase was defined in Francisella by an optical density
( O D )o f0 . 3 2A U ,w h i l eO D so f0 . 4 5A Ua n d1 . 2A U
defined mid logarithmic and stationary phase cells.
Quantitative Gene expression using GeXP™
Infection of the macrophage like cell line (RAW246.7)
was carried out as described [51]. RNA was purified
from harvested bacterial cells using the protocol from
RNeasy Kit (QIAGEN) and quantitated using UV detec-
tion at 260 nm and 280 nm. The GenomeLab™ GeXP
Genetic Analysis System (Beckman) was used for quan-
titative gene expression analysis of the selected meta-
bolic transcriptome of F. tularensis.G e X Pe m p l o y s
eXpress Profiling (XP-PCR), a patented technology for
multiplex gene expression profiling analysis by which up
to 30 genes can be easily multiplexed in the same reac-
tion. We used a protocol that comes with GeXP Reagent
kits that involved five basic steps: 1) Primer design; 2)
cDNAsynthesis; 3) PCR; 4) Separation on the Genome-
Lab GeXP Genetic Analysis System; 5) Fragment Analy-
sis and Expression Profiling. The data was then analyzed
using the GeXP analysis proprietary software (Beckman,
Inc.), Excel (Microsoft, Inc.) and Matlab (Mathworks,
Inc.). Primers were designed using proprietary software
provided by Beckman (Additional File S7).
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